IBDEI0B7 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14910,1,5,0)
 ;;=5^Vulvar Pruritis
 ;;^UTILITY(U,$J,358.3,14910,2)
 ;;=^100071
 ;;^UTILITY(U,$J,358.3,14911,0)
 ;;=V18.0^^95^852^21
 ;;^UTILITY(U,$J,358.3,14911,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14911,1,4,0)
 ;;=4^V18.0
 ;;^UTILITY(U,$J,358.3,14911,1,5,0)
 ;;=5^Family h/o Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,14911,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,14912,0)
 ;;=V16.0^^95^852^13
 ;;^UTILITY(U,$J,358.3,14912,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14912,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,14912,1,5,0)
 ;;=5^Family h/o Cancer of GI Tract
 ;;^UTILITY(U,$J,358.3,14912,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,14913,0)
 ;;=V16.1^^95^852^14
 ;;^UTILITY(U,$J,358.3,14913,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14913,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,14913,1,5,0)
 ;;=5^Family h/o Cancer of Lung
 ;;^UTILITY(U,$J,358.3,14913,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,14914,0)
 ;;=V19.6^^95^852^7
 ;;^UTILITY(U,$J,358.3,14914,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14914,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,14914,1,5,0)
 ;;=5^Family h/o Allergic Disorder
 ;;^UTILITY(U,$J,358.3,14914,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,14915,0)
 ;;=V18.2^^95^852^8
 ;;^UTILITY(U,$J,358.3,14915,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14915,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,14915,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,14915,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,14916,0)
 ;;=V17.5^^95^852^10
 ;;^UTILITY(U,$J,358.3,14916,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14916,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,14916,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,14916,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,14917,0)
 ;;=V17.7^^95^852^9
 ;;^UTILITY(U,$J,358.3,14917,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14917,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,14917,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,14917,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,14918,0)
 ;;=V19.0^^95^852^11
 ;;^UTILITY(U,$J,358.3,14918,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14918,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,14918,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,14918,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,14919,0)
 ;;=V16.3^^95^852^12
 ;;^UTILITY(U,$J,358.3,14919,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14919,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,14919,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,14919,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,14920,0)
 ;;=V16.41^^95^852^15
 ;;^UTILITY(U,$J,358.3,14920,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14920,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,14920,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,14920,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,14921,0)
 ;;=V16.42^^95^852^16
 ;;^UTILITY(U,$J,358.3,14921,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14921,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,14921,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,14921,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,14922,0)
 ;;=V16.43^^95^852^17
 ;;^UTILITY(U,$J,358.3,14922,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14922,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,14922,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,14922,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,14923,0)
 ;;=V19.5^^95^852^19
 ;;^UTILITY(U,$J,358.3,14923,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14923,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,14923,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,14923,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,14924,0)
 ;;=V19.2^^95^852^20
 ;;^UTILITY(U,$J,358.3,14924,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14924,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,14924,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,14924,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,14925,0)
 ;;=V17.3^^95^852^23
 ;;^UTILITY(U,$J,358.3,14925,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14925,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,14925,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,14925,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,14926,0)
 ;;=V16.6^^95^852^24
 ;;^UTILITY(U,$J,358.3,14926,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14926,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,14926,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,14926,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,14927,0)
 ;;=V18.61^^95^852^27
 ;;^UTILITY(U,$J,358.3,14927,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14927,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,14927,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,14927,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,14928,0)
 ;;=V17.0^^95^852^28
 ;;^UTILITY(U,$J,358.3,14928,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14928,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,14928,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,14928,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,14929,0)
 ;;=V19.4^^95^852^29
 ;;^UTILITY(U,$J,358.3,14929,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14929,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,14929,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,14929,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,14930,0)
 ;;=V17.1^^95^852^30
 ;;^UTILITY(U,$J,358.3,14930,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14930,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,14930,1,5,0)
 ;;=5^Family h/o Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,14930,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,14931,0)
 ;;=V16.8^^95^852^26
 ;;^UTILITY(U,$J,358.3,14931,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14931,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,14931,1,5,0)
 ;;=5^Family h/o Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,14931,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,14932,0)
 ;;=V11.1^^95^852^35
 ;;^UTILITY(U,$J,358.3,14932,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14932,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,14932,1,5,0)
 ;;=5^Personal h/o Affective Disorder
 ;;^UTILITY(U,$J,358.3,14932,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,14933,0)
 ;;=V15.89^^95^852^49
 ;;^UTILITY(U,$J,358.3,14933,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14933,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,14933,1,5,0)
 ;;=5^Personal h/o Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,14933,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,14934,0)
 ;;=V11.3^^95^852^36
 ;;^UTILITY(U,$J,358.3,14934,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14934,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,14934,1,5,0)
 ;;=5^Personal h/o Alcoholism
 ;;^UTILITY(U,$J,358.3,14934,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,14935,0)
 ;;=V15.07^^95^852^37
 ;;^UTILITY(U,$J,358.3,14935,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14935,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,14935,1,5,0)
 ;;=5^Personal h/o Allerlgy to Latex
 ;;^UTILITY(U,$J,358.3,14935,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,14936,0)
 ;;=V13.4^^95^852^38
 ;;^UTILITY(U,$J,358.3,14936,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14936,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,14936,1,5,0)
 ;;=5^Personal h/o Arthritis
 ;;^UTILITY(U,$J,358.3,14936,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,14937,0)
 ;;=V12.59^^95^852^43
 ;;^UTILITY(U,$J,358.3,14937,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14937,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,14937,1,5,0)
 ;;=5^Personal h/o Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,14937,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,14938,0)
 ;;=V45.81^^95^852^44
 ;;^UTILITY(U,$J,358.3,14938,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14938,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,14938,1,5,0)
 ;;=5^Personal h/o Coronary Bypass
 ;;^UTILITY(U,$J,358.3,14938,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,14939,0)
 ;;=V15.84^^95^852^48
 ;;^UTILITY(U,$J,358.3,14939,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14939,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,14939,1,5,0)
 ;;=5^Personal h/o Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,14939,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,14940,0)
 ;;=V15.85^^95^852^68
 ;;^UTILITY(U,$J,358.3,14940,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14940,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,14940,1,5,0)
 ;;=5^Personal h/o Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,14940,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,14941,0)
 ;;=V10.72^^95^852^52
 ;;^UTILITY(U,$J,358.3,14941,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14941,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,14941,1,5,0)
 ;;=5^Personal h/o Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,14941,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,14942,0)
 ;;=V15.3^^95^852^53
 ;;^UTILITY(U,$J,358.3,14942,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14942,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,14942,1,5,0)
 ;;=5^Personal h/o Irradiation
 ;;^UTILITY(U,$J,358.3,14942,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,14943,0)
 ;;=V10.82^^95^852^60
 ;;^UTILITY(U,$J,358.3,14943,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14943,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,14943,1,5,0)
 ;;=5^Personal h/o Mal Melanoma of Skin
 ;;^UTILITY(U,$J,358.3,14943,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,14944,0)
 ;;=V15.81^^95^852^34
 ;;^UTILITY(U,$J,358.3,14944,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14944,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,14944,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,14944,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,14945,0)
 ;;=V10.43^^95^852^66
 ;;^UTILITY(U,$J,358.3,14945,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14945,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,14945,1,5,0)
 ;;=5^Personal h/o Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,14945,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,14946,0)
 ;;=V10.46^^95^852^69
 ;;^UTILITY(U,$J,358.3,14946,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14946,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,14946,1,5,0)
 ;;=5^Personal h/o Prostate Cancer
 ;;^UTILITY(U,$J,358.3,14946,2)
 ;;=Hx of Prostate Cancer^295224
